Tolerance for Failure and Corporate Innovation

被引:645
作者
Tian, Xuan [1 ]
Wang, Tracy Yue [2 ]
机构
[1] Indiana Univ, Kelley Sch Business, Bloomington, IN 47405 USA
[2] Univ Minnesota, Carlson Sch Management, Minneapolis, MN 55455 USA
关键词
CAREER CONCERNS; PRIVATE EQUITY; VENTURE; INVESTMENT; BANKRUPTCY; MONEY;
D O I
10.1093/rfs/hhr130
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
Based on a sample of venture capital (VC)-backed IPO firms, we examine whether tolerance for failure spurs corporate innovation. We develop a novel measure of VC investors' failure tolerance by examining their willingness to continue investing in underperforming ventures. We find that IPO firms backed by more failure-tolerant VC investors are significantly more innovative and VC failure tolerance is particularly important for ventures that are subject to high failure risk. We show that these results are not driven by endogenous matching between failure-tolerant VC firms and start-ups with high ex ante innovative potential. We also examine the determinants of the cross-sectional heterogeneity in a VC firm's failure tolerance. We find that both capital constraints and career concerns can negatively distort a VC firm's failure tolerance. Less experienced VC firms are more exposed to these distortions, making them less failure tolerant than are more established VC firms.
引用
收藏
页码:211 / 255
页数:45
相关论文
共 44 条
[1]  
Acharya V., 2010, WORKING PAPER
[2]   Bankruptcy Codes and Innovation [J].
Acharya, Viral V. ;
Subramanian, Krishnamurthy V. .
REVIEW OF FINANCIAL STUDIES, 2009, 22 (12) :4949-4988
[3]  
Acharya Viral V., 2009, Working paper
[4]   Estimating the cost of new drug development: Is it really $802 million? [J].
Adams, CP ;
Brantner, VV .
HEALTH AFFAIRS, 2006, 25 (02) :420-428
[5]  
Aghion P., 2009, Working Paper
[6]  
[Anonymous], 2005, ART MONTHLY JUL, V288, P16
[7]  
[Anonymous], 2004, The venture capital cycle
[8]  
[Anonymous], 1987, EC POLICY TECHNOLOGI
[9]  
[Anonymous], 2001, NBER PATENT CITATION
[10]  
[Anonymous], 2007, WORKING PAPER